[18F]FDG-PET/CT Heterogeneity in Patients with Metastatic, Well-Differentiated Pancreatic Neuroendocrine Tumours

被引：0

作者：

Ortolani, S. ^{[1
]}

Cingarlini, S. ^{[1
]}

Citton, E. ^{[1
]}

Crosara, S. ^{[2
]}

De Robertis, R. ^{[3
]}

Grego, E. ^{[1
]}

Vallerio, P. ^{[4
]}

D'Onofrio, M. ^{[2
]}

Butturini, G. ^{[5
]}

Landoni, L. ^{[6
]}

Capelli, P. ^{[7
]}

Zuffante, M. ^{[8
]}

Ferdeghini, M. ^{[8
]}

Salgarello, M. ^{[9
]}

Tortora, G. ^{[1
]}

机构：

[1] GB Rossi Univ Hosp Verona, Comprehens Canc Network, Dept Oncol, Verona, Italy

[2] GB Rossi Univ Hosp Verona, Comprehens Canc Network, Dept Radiol, Verona, Italy

[3] Casa Cura Pederzoli, Comprehens Canc Network, Dept Radiol, Peschiera Del Garda, VR, Italy

[4] GB Rossi Univ Hosp Verona, Comprehens Canc Network, Dept Internal Med, Verona, Italy

[5] Casa Cura Pederzoli, Comprehens Canc Network, Dept Pancreat Surg, Peschiera Del Garda, VR, Italy

[6] GB Rossi Univ Hosp Verona, Comprehens Canc Network, Dept Pancreat Surg, Verona, Italy

[7] GB Rossi Univ Hosp Verona, Comprehens Canc Network, Dept Pathol, Verona, Italy

[8] GB Rossi Univ Hosp Verona, Comprehens Canc Network, Dept Nucl Med, Verona, Italy

[9] Osped Sacro Cuore Don Calabria, Comprehens Canc Network, Dept Nucl Med, Negrar, VR, Italy

来源：

NEUROENDOCRINOLOGY | 2016年 / 103卷

关键词：

18F-FDG-PET/CT; Heterogeneity; Pancreatic NETs;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

I20

引用

页码：61 / 61

页数：1

共 50 条

[31] [18F]FDG-PET/CT and long-term response to everolimus in advanced neuroendocrine neoplasia
Rinzivillo, M.
Prosperi, D.
Mazzuca, F.
Magi, L.
Iannicelli, E.
Pilozzi, E.
Franchi, G.
Silveri, G. Gentiloni
Laghi, A.
Annibale, B.
Signore, A.
Panzuto, F.
ANNALS OF ONCOLOGY, 2020, 31 : S782 - S782
[32] [18F]FDG-PET/CT and long-term responses to everolimus in advanced neuroendocrine neoplasia
Rinzivillo, M.
Prosperi, D.
Mazzuca, F.
Magi, L.
Iannicelli, E.
Pilozzi, E.
Franchi, G.
Laghi, A.
Annibale, B.
Signore, A.
Panzuto, F.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (04) : 811 - 818
[33] [18F]FDG-PET/CT and long-term responses to everolimus in advanced neuroendocrine neoplasia
M. Rinzivillo
D. Prosperi
F. Mazzuca
L. Magi
E. Iannicelli
E. Pilozzi
G. Franchi
A. Laghi
B. Annibale
A. Signore
F. Panzuto
Journal of Endocrinological Investigation, 2021, 44 : 811 - 818
[34] Advantages of 18F FDG-PET/CT over Conventional Staging for Sarcoma Patients
Nemeth, Zsuzsanna
Boer, Katalin
Borbely, Katalin
PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 131 - 136
[35] Clinical Utility of [18F]FDG-PET /CT in Pericardial Disease
Min-Sun Kim
Eun-Kyung Kim
Joon Young Choi
Jae K. Oh
Sung-A Chang
Current Cardiology Reports, 2019, 21
[36] [18F]-FDG-PET/CT Early Response to Nivolumab in NSCLC
Bellevre, Dimitri
Petyt, Gegory
Collet, Guillaume
Hossein-Foucher, Claude
Baldacci, Simon
Baranzelli, Anne
Semah, Franck
Cortot, Alexis
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S402 - S402
[37] [18F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience
Bertagna, Francesco
Treglia, Giorgio
Leccisotti, Lucia
Bosio, Giovanni
Motta, Federica
Giordano, Alessandro
Giubbini, Raffaele
JAPANESE JOURNAL OF RADIOLOGY, 2012, 30 (05) : 415 - 421
[38] Influence of 18F FDG-PET/CT on radiotherapy planning in patients with cervical cancer
Cegla, P.
Cholewinski, W.
Roszak, A.
Smolen, M.
Kazmierska, J.
Urbanski, B.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S146 - S146
[39] [18F]FDG-PET/CT in extranodal non Hodgkin lymphoma
Sollini, Martina
Zangheri, Barbara
Calabrese, Luigi
Gasparini, Massimo
JOURNAL OF NUCLEAR MEDICINE, 2016, 57
[40] [18F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience
Francesco Bertagna
Giorgio Treglia
Lucia Leccisotti
Giovanni Bosio
Federica Motta
Alessandro Giordano
Raffaele Giubbini
Japanese Journal of Radiology, 2012, 30 : 415 - 421

← 1 2 3 4 5 →